Vivo Capital’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
Other funds holding NERV
Vivo Capital's NERV Position: Q3 2026 in Review
Vivo Capital held its Minerva Neurosciences (NERV) position steady in Q3 2026 at 4,322,747 shares worth $14.5M. The position accounts for 1.59% of the portfolio, ranked #23.
Vivo Capital first reported a position in NERV in Q2 2016 and has held it in 5 quarters since. The position peaked at $26M in Q1 2026. 69 funds tracked by Wall St. Rank hold NERV as of Q3 2026.
- Vivo Capital held 4,322,747 shares of Minerva Neurosciences worth $14.5M as of Q3 2026.
- Vivo Capital left its Minerva Neurosciences share count unchanged in Q3 2026.
- Minerva Neurosciences made up 1.59% of Vivo Capital's portfolio in Q3 2026, its #23 holding.
- Vivo Capital first reported a position in Minerva Neurosciences in Q2 2016 and has held it in 5 quarters since.
- Vivo Capital's Minerva Neurosciences position peaked at $26M in Q1 2026.
- 69 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2026.
Based on Vivo Capital's 13F filing for Q3 2026, filed 13 Nov 2026.